EFFECT OF FATTY ACID BASED FUNCTIONAL LIPIDOMICS IN WOMEN WITH BREAST CANCER
DOI:
https://doi.org/10.22159/ajpcr.2019.v12i10.34888Keywords:
Functional lipidomics, Fatty acids, Breast cancer, Cell membrane fatty acid profile, Fatty acid profileAbstract
Objective: Lipid metabolism alteration is a prominent feature during malignant transformation. We investigated the difference in plasma fatty acids (FAs) and molecular biomarkers in breast cancer women and controls.
Methods: This comparative study was carried out on eighty breast cancer women and forty control women. FAs were analyzed in gas chromatography and calculated as a percentage of total FAs. FA molecular markers were estimated by the FA data. Non-parametric statistical tests were used.
Results: Saturated FAs were higher in the case group. Control group had higher linoleic acid (p=0.04), suggesting decreased desaturase activity. N-6 FAs were higher and n-3 FAs were lower in breast cancer cases. The n6/n3 ratio, cardiovascular risk ratio (p<0.001), and inflammatory risk ratio were high, whereas saturation index and unsaturation index (p=0.05) were lower in breast cancer cases.
Conclusion: Lipidomics of the cell membrane is significantly influenced by FAs, and the dietary FAs regulate the enzymatic activities in the FA metabolism pathway.
Downloads
References
Al-biati HA, Sahib AS, Mahmood AN. Effects of tamoxifen or letrozole on lipid profile, Vitamin D and estradiol serum levels in obese postmenopausal woman with breast cancer. Int J Pharm Pharm Sci 2017;9:141-4.
Braicu C, Chiorean R, Irimie A, Chira S, Tomuleasa C, Neagoe E, et al., Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy. Expert Rev Mol Med 2016;18:e18.
Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 2004;79:935-45.
Liu J, Ma DW. The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancer. Nutrients 2014;6:5184-223.
Bassett JK, Hodge AM, English DR, MacInnis RJ, Giles GG. Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk. Cancer Causes Control 2016;27:759-73.
Hilvo M, Oresie AM. Regulation of lipid metabolism in breast cancer provides diagnostic and therapeutic opportunities. Clin Lipidol 2012;7:177-8.
Metcalfe LD, Schmitz AA, Pelka JR. Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Anal Chem 1966;38:514-5.
Amézaga J, Arranz S, Urruticoechea A, Ugartemendia G, Larraioz A, Louka M, et al., Altered red blood cell membrane fatty acid profile in cancer patients. Nutrients 2018;10:E1853.
Pironi L, Guidetti M, Verrastro O, Iacona C, Agostini F, Pazzeschi C, et al., Functional lipidomics in patients on home parenteral nutrition: Effect of lipid emulsions. World J Gastroenterol 2017;23:4604-14.
Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: The role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech 2013;6:1353-63.
Kumar A, Jha S, Pattanayak SP. Effect of naringenin on lipids, lipoproteins and lipid metabolizing enzymes in 7,12-deimethyl benz(a) anthracene induced mammary carcinogenesis is SD rats. Int J Pharm Pharm Sci 2016;8:154-8.
Pamplona R. Membrane phospholipids, lipoxidative damage and molecular integrity: A causal role in aging and longevity. Biochim Biophys Acta 2008;1777:1249-62.
Maulucci G, Cohen O, Daniel B, Sansone A, Petropoulou PI, Filou S, et al., Fatty acid-related modulations of membrane fluidity in cells: Detection and implications. Free Radic Res 2016;50:S40-50.
Igal RA. Stearoyl coA desaturase-1: New insights into a central regulator of cancer metabolism. Biochim Biophys Acta 2016;1861:1865-80.
Pala V, Krogh V, Muti P, Chajès V, Riboli E, Micheli A, et al., Erythrocyte membrane fatty acids and subsequent breast cancer: A prospective Italian study. J Natl Cancer Inst 2001;93:1088-95.
Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.
Zhou J, Suzuki T, Kovacic A, Saito R, Miki Y, Ishida T, et al., Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer. Cancer Res 2005;65:657-63.
Pan MR, Hou MF, Chang HC, Hung WC. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. J Biol Chem 2008;283:11155-63.
Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008;233:674-88.
Zanoaga O, Jurj A, Raduly L, Cojocneanu-Petric R, Fuentes-Mattei E, Wu O, et al., Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer. Exp Ther Med 2018;15:1167-76.
Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, Dimri GP. Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 2010;31:489-95.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
